An Update on the Assessment and Therapeutic Management of Cognitive Decline in Patients with Multiple Sclerosis

An Update on the Assessment and Therapeutic Management of Cognitive Decline in Patients with Multiple Sclerosis is organized by AcademicCME.,Program Overview:,This CME program will provide an update on the assessment and therapeutic management of cognitive decline in patients with multiple sclerosis (MS). The expert faculty, Dr. Ann Bass, will first cover multiple sclerosis cognition dysfunction in the modern treatment era, highlighting various measurement tools. Following, recent clinical trial data regarding the treatment and prevention of cognitive decline will be reviewed, including a discussion of modifiable risk factors for gray matter atrophy. Dr. Bass will conclude with implications for clinical practice, utilizing a case-based approach. Upon completion of this CME activity, learners will be able to better assess and manage cognitive decline in their multiple sclerosis patients.,Learning Objectives:,• Review the science and assessment of cognition in patients with multiple sclerosis,• Analyze recent data and clinical applications of therapeutics that manage cognition, including S1P-based therapies